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Summary
Casitas B cell lymphoma (Cbl) proteins are negative
regulators for T cell antigen receptor (TCR) signaling.
Their role in thymocyte development remains unclear.
Here we show that simultaneous inactivation of c-Cbl
and Cbl-b in thymocytes enhanced thymic negative
selection and altered the ratio of CD4+ and CD8+ T
cells. Strikingly, the mutant thymocytes developed
into CD4+- and CD8+-lineage T cells independent of
the major histocompatibility complex (MHC), indicat-
ing that the CD4+- and CD8+-lineage development
programs are constitutively active in the absence of
c-Cbl and Cbl-b. The mutant double-positive (DP)
thymocytes exhibited spontaneous hyperactivation
of nuclear factor-kappa B (NF-kB). Additionally, they
failed to downregulate the pre-TCR and pre-TCR sig-
naling. Thus, our data indicate that Cbl proteins play
a critical role in establishing the MHC-dependent
CD4+ and CD8+ T cell development programs. They
likely do so by suppressing MHC-independent NF-kB
activation, possibly through downmodulating pre-
TCR signaling in DP thymocytes.
Introduction
T lymphopoiesis is a sequential developmental process
regulated by thymic environmental signals (Fowlkes and
Pardoll, 1989; Love and Chan, 2003; von Boehmer,
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9500 Euclid Avenue, Cleveland, Ohio 44195.1988). The first step of T cell development involves suc-
cessive rearrangements of the V-(D)-J genes in CD4 and
CD8 double-negative (DN) T precursors, and only those
cells with a successfully rearranged TCRb gene may de-
velop further into CD4 and CD8 DP stage of thymocytes.
This step in T cell development is controlled by signaling
of growth factor receptors such as interleukine-7 recep-
tor (IL-7R) and pre-TCR and occurs independently from
the MHC because pre-TCR signaling is constitutively ac-
tive in the absence of the MHC (Hayday et al., 1999; von
Boehmer and Fehling, 1997). At the DP stage, thymo-
cytes may decide to become either CD4+ helper-T (Th)
or CD8+ cytotoxic-T (Tc) cells and are positively and
negatively selected based on the interaction between
the TCR and the MHC expressed by thymic accessory
cells (Kaye et al., 1989; Sha et al., 1988; Teh et al.,
1988). While thymocytes expressing a TCR that recog-
nize MHC-I choose CD8+ T cell fate and develop into
Tc cells, cells that express a TCR recognizing MHC-II
commit to CD4+ lineage and become Th cells (Cosgrove
et al., 1991; Grusby et al., 1991; Zijlstra et al., 1990).
Development of CD4+ and CD8+ T cells is regulated by
signals delivered by the TCR; however, it remains un-
clear how the incoming TCR signals are connected to
the CD4+ and CD8+ lineage-development program. Cur-
rent opinion indicates that engagement of the TCR with
MHC initiates a TCR-downstream signaling cascade,
starting with tyrosine phosphorylation of the immunore-
ceptor tyrosine-based activation motifs (ITAMs) of the
CD3 complex by the Src-family tyrosine kinase Lck (lym-
phocyte-specific protein tyrosine kinase) (Weiss and
Littman, 1994). The phosphorylated ITAMs then recruit
tyrosine kinase Zap70 (zeta-chain associated protein
70 kDa) to the engaged TCR complexes, leading to
Zap70 activation. Upon activation, Zap70 phosphory-
lates membrane protein LAT (linker for activation of T
cells), which then assembles a complex of multisignal-
ing molecules, including Grb2 (growth-factor receptor
binding protein 2), Gads (Grb2-related adaptor protein),
SLP-76 (the SH2-domain-containing leukocyte phos-
phoprotein of 76 kDa), Vav, PLCg-1 (phospholipase
Cgamma-1), and Itk (interleukine-2 tyrosine kinase)
(Koretzky and Myung, 2001; Lucas et al., 2003). Coor-
dination between these signaling components leads
to multiple downstream cellular responses, including
Ca2+ mobilization, cytoskeleton reorganization, and ac-
tivation of various nuclear factors that eventually deter-
mine the various T cell development programs.
The Cbl family of proteins are signaling adaptors that
associate with many different receptors and intracellular
signaling components (Rao et al., 2002; Thien et al.,
2001). c-Cbl and Cbl-b, two highly homologous mem-
bers of the Cbl family, are coexpressed in hematopoi-
etic-lineage cells and function as E3-ubiquitin ligases
(Joazeiro et al., 1999). Biochemical analyses reveal
that Cbl proteins promote the ubiquitination of several
Cbl-associated proteins, thereby regulating the degra-
dation or intracellular association of these molecules
(Liu, 2004). In the immune system, protein ubiquitination
has been implicated in the regulation of T-lymphocyte
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572differentiation into Th2 cells, as well as in the induction
of immune tolerance (Fang et al., 2002; Naramura
et al., 2002). However, it remains unclear whether Cbl
proteins also control the development of early T cells.
c-Cbl and Cbl-b are differentially expressed in thymo-
cytes and mature T cells (Naramura et al., 2002). Such
developmentally regulated pattern of expression is con-
sistent with their predominant role either in thymocyte
development or in peripheral T cell activation (Bachma-
ier et al., 2000; Chiang et al., 2000; Naramura et al., 1998,
2002). At the molecular level, c-Cbl and Cbl-b share
a high sequence homology and are coexpressed in de-
veloping thymocytes (Naramura et al., 2002), thus sug-
gesting that they may have a redundant function in early
T cell development and differentiation. In this report, we
show that simultaneous ablation of c-Cbl and Cbl-b
in thymocytes resulted in spontaneous development
of CD4+ and CD8+ T cells in the absence of the MHC.
The mutant DP thymocytes failed to downmodulate
pre-TCR and exhibited constitutive pre-TCR signaling.
These results together indicate that Cbl proteins are
the key players in switching pre-TCR signaling to TCR
signaling, a process critical for establishing the MHC-
restricted repertoire of CD4+ and CD8+ T cells.
Results
Generation of c-Cbl and Cbl-b Double-Deficient Mice
Homozygous germline c-Cbl and Cbl-b double-deficient
mice died before day 10.5 of embryogenesis (E10.5)
(Naramura et al., 2002). To study the function of Cbl pro-
teins in T cell development, we generated T cell-specific
c-Cbl and Cbl-b double-deficient mice with the Cre-loxP
system (Naramura et al., 2002) (see also Figure S1A in
the Supplemental Data available online). These mice
were homozygous for the Cbl-b null (Cblb2/2) and
c-Cbl floxed (Cblf/f) mutations and carried an Lck-cre
transgene that specifically expressed the Cre recombi-
nase in thymocytes (Takahama et al., 1998). Our results
indicated that the Lck-Cre transgenic mice mediated de-
letion of floxed gene in as early as DN3 stage of thymo-
cytes (Figure S1B). We confirmed the absence of c-Cbl
and Cbl-b proteins in the purified DP thymocytes of
the resulting c-Cbl and Cbl-b double-deficient mice by
immunoblot hybridization (Figure S1C). Hereafter, we
refer to these T cell-specific c-Cbl and Cbl-b double-
deficient (Cblf/f, Cblb2/2, Lck-cre) mice as Cbl double-
deficient (Cbl2/2, Cblb2/2) mice.
The Cbl Double Deficiency Enhances Thymic
Negative Selection
It has been shown previously that both c-Cbl-deficient
(Cbl2/2) and Cbl-b-deficient (Cblb2/2) mice have normal
numbers of thymocytes (Bachmaier et al., 2000; Chiang
et al., 2000; Naramura et al., 1998). In contrast, we found
that Cbl2/2, Cblb2/2 mice had significantly lower num-
bers of thymocytes than did wild-type controls (Fig-
ure 1A). Analysis of DN thymocytes revealed that the
total numbers of DN1-4 subsets were mostly compara-
ble betweenCbl2/2, Cblb2/2 and wild-type mice, except
a slight increase in DN3 thymocytes in the mutant mice
(p < 0.001) (Figures 1A and 1B). However, the numberof DP thymocytes in Cbl2/2, Cblb2/2 mice was reduced
to about 30%–40% of that in wild-type controls (p <
0.001) (Figure 1A). The impaired DP T cell development
could not be explained by the deficiency in TCRb gene
rearrangement, as shown by the fact that we detected
comparable levels of dsDNA breaks at TCRb recombi-
nation signal sequences (RSSs) in purified mutant
DN2-4 cells (Figure S2A), nor could it be explained by
lack of DN3-DN4 expansion (b-selection), as shown by
the fact that the mutant DN3 and DN4 cells proliferated
as efficiently as did the wild-type cells (Figure S2B).
These results thus suggest that the reduction of thymo-
cyte numbers happens after the DN stage.
The total number of DP thymocytes could be affected
by thymic positive and negative selection, so we next
determined whether thymic selection was altered in
the absence of c-Cbl and Cbl-b. To this end, we crossed
Cbl2/2, Cblb2/2 mice to H-Y and 5C.C7 TCR transgenic
mice, respectively, and examined thymic positive and
negative selection in the resulting Cbl2/2, Cblb2/2, H-Y
and Cbl2/2, Cblb2/2, 5C.C7 TCR transgenic mice. We
found that in the absence of Cbl proteins, CD8+ T cells
were negatively selected in male H-Y TCR transgenic
mice as efficiently as that in wild-type H-Y TCR trans-
genic mice (Figure 1C); however, in female H-Y TCR
transgenic mice, the ablation of Cbl proteins appeared
to convert thymic positive selection of H-Y TCR-
expressing CD8+ T cells into negative selection; DP
and CD8+ thymocytes were markedly diminished in
thymi of Cbl2/2, Cblb2/2 mice (Figure 1D). Conversion
of positive selection into negative selection was also ob-
served in the CD4+ T cell compartment: both DP and
CD4+ thymocytes were deleted in Cbl2/2, Cblb2/2 but
not in wild-type 5C.C7 TCR transgenic mice (Figure 1D).
Based on these results, we conclude that the Cbl double
deficiency enhances thymic negative selection, leading
to deletion of T cells that are usually positively selected
in wild-type mice. Moreover, we propose that the en-
hanced negative selection is at least one of the reasons
responsible for the reduced number of DP thymocytes in
the mutant mice.
Altered Ratio of CD8+ to CD4+ Thymocytes in Cbl
Double-Deficient Mice
In addition to the reduction in the numbers of DP cells,
the Cbl double deficiency markedly altered the ratio of
CD8+ versus CD4+ thymocytes (Figures 2A and 2B).
While the wild-type, Cbl2/2, and Cblb2/2 mice each
had approximately 2–3 times more CD4+ than CD8+ thy-
mocytes, Cbl2/2, Cblb2/2 mice possessed 20%–50%
more CD8+ than CD4+ T cells (p < 0.001). This result sug-
gests that the Cbl double deficiency alters the CD4+ and
CD8+ lineage-development program.
We have previously demonstrated that Cbl2/2,
Cblb2/2 mice develop severe vasculitis in adulthood
and become moribund by the age of 4–6 months (Nara-
mura et al., 2002). To exclude the possibility that the in-
flammation is responsible for the reduced mutant DP
cells and biased ratio of CD4+ versus CD8+ T cells, we
transferred mixed bone marrow (BM) stem cells (at a
1:1 ratio) from Cbl2/2, Cblb2/2 (H-2Kd/b) and wild-type
(H-2Kb/b) mice into Rag22/2 (H-2Kb/b) mice and
analyzed the donor-derived DP, CD4+, and CD8+
Cbl in the MHC-Dependent Development of T Cells
573Figure 1. Flow Cytometric Analyses of the Thymocyte Subsets and Thymic Positive and Negative Selection
(A) Comparison of the thymocyte subsets in Cbl2/2, Cblb2/2 and wild-type mice. Shown are the mean values of cell numbers of each thymocyte
subset. DP, CD4CD8 double-positive thymocytes; DN, CD4CD8 double-negative thymocytes; DN1-4, CD4CD8 double-negative 1 to 4 subpop-
ulations of thymocytes as defined by cell-surface markers c-Kit, CD25, and CD44 (Godfrey et al., 1993); DN1 cells represent c-Kit+ cells in gated
CD44+ CD252 population. The results were summarized from 4- to 5-week-old Cbl2/2, Cblb2/2 (n = 5) and wild-type or Cblb2/2 mice (n = 5).
(B) Flow cytometric analysis of DN thymocyte subsets from wild-type and Cbl2/2, Cblb2/2 mice. Cells were stained with anti-CD25-FITC, anti-
CD44-APC, anti-c-Kit-PE, and biotinylated anti-CD4, CD8, CD3, Mac-1, Gr-1, NK1.1, TCRgd, and B220, followed by straptavidin-PE-Cy7 stain-
ing. DN cells are gated DN (CD42CD82CD32Mac-12Gr-12NK1.12 TCRgd2B2202) thymocytes. Shown are the profiles of anti-CD44 and CD25
staining of the c-Kit+ CD44+/2 and c-Kit2 CD442 populations among the gated DN cells.
(C) Thymic negative selection. Shown are dot plot analyses of anti-CD4 and anti-CD8 staining of thymocytes from wild-type and Cbl2/2, Cblb2/2
non-TCR transgenic mice (left) and male wild-type and Cbl2/2, Cblb2/2 H-Y TCR transgenic mice (right).
(D) Thymic positive selection. Dot plots represent anti-CD4 and anti-CD8 staining profiles of thymocytes from female wild-type and Cbl2/2,
Cblb2/2 H-Y TCR transgenic mice (left) or wild-type and Cbl2/2, Cblb2/2 5C.C7 TCR transgenic mice (right). 5C.C7 TCR transgenic mice
were of H-2k/b background.thymocytes in the recipient Rag22/2 mice (Figure 2C).
Cbl2/2, Cblb2/2 and wild-type thymocytes could be dis-
tinguished by the cell-surface marker H-2Kd. We found
that in the recipient mice, the total number of Cbl2/2,
Cblb2/2 thymocytes was approximately one-third of
the wild-type donor thymocytes (p < 0.01), consistent
with our finding that the Cbl double deficiency reduced
the total number of thymocytes (Figure 1). In addition,
the ratio of CD8+ to CD4+ T cells derived from Cbl2/2,
Cblb2/2 donors was also higher than that from wild-
type controls. These results thus refute the notion that
the reduced number of DP T cells and altered ratio of
CD8+ versus CD4+ T cells in Cbl2/2, Cblb2/2 mice are
caused by inflammatory cytokines. Taken together, we
conclude that c-Cbl and Cbl-b regulate the T cell-
intrinsic programs that control the total number of thy-
mocytes and define the ratio of CD4+ and CD8+ T cells
during thymic development.The Cbl Double Deficiency Leads
to MHC-Independent CD4+ and CD8+
T Cell Development
The increase in CD8+ thymocytes in Cbl2/2, Cblb2/2
mice suggested that the Cbl double deficiency might en-
hance thymic positive selection or attenuate negative
selection of CD8+-lineage cells. To investigate this pos-
sibility, we transferred respectively fetal liver stem cells
from Cbl2/2, Cblb2/2 and Cblb2/2mice into lethally irra-
diated MHC-I-deficient mice and then examined devel-
opment of donor-derived thymocytes in the recipient
mice. Donor-derived cells can be distinguished from
the recipients based on the cell-surface marker Ly9.1.
If the increase of CD8+ T cells in Cbl2/2, Cblb2/2 mice
was a result of the altered thymic selection for CD8+-lin-
eage cells, we expect that the development of Cbl2/2,
Cblb2/2 CD8+ T cells was blocked in this experimental
setting because thymic selection of CD8+ T cells
Immunity
574Figure 2. Flow Cytometric Analysis of the Ratio of CD8+ to CD4+ Thymocytes
(A) Anti-CD4 and CD8 staining profiles of thymocytes from wild-type, Cbl2/2, Cblb2/2, and Cbl2/2, Cblb2/2 mice.
(B) Ratios of CD8+ to CD4+ thymocytes in wild-type (open bar) and Cbl2/2, Cblb2/2 (solid bar) mice. The results represent data collected from
3-week-old mice (n = 5) in each group.
(C) Flow cytometric analysis of CD4+ and CD8+ thymocytes fromRag22/2bone marrow (BM) chimera receiving mixed (1:1 ratio) BM cells from the
Cbl2/2, Cblb2/2 (H-2kd/b) and wild-type (H-2Kb/b) mice. Shown at the bottom are the CD4 and CD8 staining profiles of the gated Cbl2/2, Cblb2/2
(Kd+) or wild-type (Kd2) thymocytes. Results represent more than three independent experiments.requires TCR-MHC-I interaction. As shown in Figure 3A,
we found that CD8+ T cells were still generated from
Cbl2/2, Cblb2/2, but not MHC-I-deficient nor Cblb2/2
donor stem cells in these chimeras, thus indicating
that the increase in CD8+ T cells in Cbl2/2, Cblb2/2
mice is unlikely resulted from the enhanced positive or
attenuated negative selection for this lineage.
Alternatively, increase in CD8+ T cells in Cbl2/2,
Cblb2/2 mice could be a consequence of an altered
CD4+-and CD8+-lineage commitment program so that,
in addition to MHC-I-restricted thymocytes, some mu-
tant thymocytes that recognize MHC-II developed into
CD8+ cells. To examine this possibility, we transferred
Cbl2/2, Cblb2/2 fetal liver stem cells into irradiated
MHC-I and II double mutant mice and examined do-
nor-derived thymocyte development in the recipients.
If the Cbl double deficiency switches the fate of MHC-
II-restricted thymocytes to the CD8+ lineage, we expect
that the development of Cbl2/2, Cblb2/2 CD8+ T cells
should be blocked in MHC-I and II double-deficient
mice because in this scenario CD4+- and CD8+-lineage
determination requires interaction between the TCR
and MHC-I or MHC-II. Surprisingly, we found that in
the recipient thymi, while CD4+ and CD8+ T cells from
MHC-I and II double mutant or Cblb2/2 donor stem cells
were completely absent, they were efficiently generated
fromCbl2/2, Cblb2/2 T cell precursors (Figure 3B). Inter-
estingly, Cbl2/2, Cblb2/2 CD4+ and CD8+ T cells were
not significantly increased in the spleens and lymph no-
des of recipient MHC-I and II double mutant mice as
compared to wild-type cells (data not shown), suggest-
ing that build-up of Cbl2/2, Cblb2/2 CD4+ and CD8+
T cell populations in the periphery still requires the MHC.
Recent experiments demonstrate that enforced ex-
pression of MHC-II in BM stem cell-derived thymocytes
may promote positive selection of CD4+ and CD8+T cells in MHC-II-deficient recipient mice (Choi et al.,
2005; Li et al., 2005). To exclude the possibility that
development of T cells in MHC-deficient recipients
involved donor-derived MHC-expressing cells, we
bred Cbl2/2, Cblb2/2 mice to MHC-I and II double-
deficient mice and analyzed T cell development in the
resulting c-Cbl, Cbl-b, MHC-I, and MHC-II (MHC-Cbl)
quadruple-deficient mice (Figure 3C). We found that
the total numbers of thymocytes in Cbl-MHC quadru-
ple-deficient mice were comparable to that in Cbl2/2,
Cblb2/2 mice. Strikingly, while few CD4+ and CD8+
thymocytes were generated in MHC-I and II double-
deficient mice, both CD4+ and CD8+ T cells were as effi-
ciently generated in Cbl-MHC quadruple-deficient mice
as that in Cbl2/2, Cblb2/2 mice. Additionally, a biased
ratio of CD8+ versus CD4+ T cells was also observed in
Cbl-MHC quadruple-deficient mice (Figure 3C). These
Cbl-MHC quadruple-deficient CD4+ and CD8+ T cells re-
sembled positively selected Cbl2/2, Cblb2/2 CD4+ and
CD8+ thymocytes, as shown by the fact that the majority
of them downmodulated HSA and expressed the TCR at
the amounts comparable to that expressed by Cbl2/2,
Cblb2/2CD4+ and CD8+ T cells (Figure 3D). Additionally,
the quadruple-deficient CD4+ and CD8+ T cells ap-
peared to be functionally normal T cells rather than im-
mature CD4+ and CD8+ single-positive T cells: they pro-
liferated vigorously and secreted a high amount of IL-2
upon TCR stimulation (Figure 3E). Taken together, the
above results demonstrate that Cbl proteins play an es-
sential role in establishing the MHC-dependent CD4+
and CD8+ T cell development programs. Since Cbl2/2,
Cblb2/2 thymocytes develop into CD4+ and CD8+ T cells
in the absence of MHC-I and II, we propose that Cbl pro-
teins function as a barrier to prevent ‘‘unauthorized’’
(through TCR-MHC interaction) CD4+ and CD8+ T cell
development under physiological conditions.
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575Figure 3. Development of Cbl2/2, Cblb2/2 CD4+ and CD8+ Thymocytes in MHC-I Deficient, MHC-I and II Double-Deficient BM Chimeric, and
Cbl-MHC Quadruple-Deficient Mice
(A and B) Fetal liver cells (Ly9.1+) were collected from 14-day-old Cbl2/2, Cblb2/2 and wild-type embryos and transferred into irradiated-MHC-I
deficient or MHC-I and II double-deficient (Ly9.12) mice by i.v. injection. One month later, mice were sacrificed, and thymocytes were analyzed by
flow cytometry. Shown are anti-CD4 and CD8 staining profiles of gated recipient (Ly9.12) or donor (Ly9.1+) derived cells from MHC-I-deficient
(B2m2/2) (A) or MHC-I and II double-deficient (B) recipient (B2m2/2, Abb2/2) mice.
(C) Flow cytometric analysis of thymocyte subsets in Cbl-MHC quadruple-deficient mice. Shown are anti-CD4 and anti-CD8 staining profiles of
thymocytes from wild-type, MHC-I and II double-deficient (B2m2/2, Abb2/2), Cbl double-deficient (Cbl2/2, Cblb2/2), and Cbl-MHC quadruple-
deficient (Cbl2/2, Cblb2/2, B2m2/2, Abb2/2) mice.
(D) Expression of HSA and TCRb on Cbl2/2, Cblb2/2 DP, CD4+, and CD8+ thymocytes. Thymocytes from wild-type, MHC-I and II double-
deficient, Cbl double-deficient, and Cbl-MHC quadruple-deficient mice were stained with anti-CD4 and CD8 in combination with either anti-
HSA or anti-TCRb chain. Shown are histograms of HSA and TCRb expression on the gated DP (shadow), CD4+ (solid line), CD8+ (dashed line)
thymocytes. Results are representatives of three independent experiments.
(E) Proliferation and IL-2 production of Cbl-MHC quadruple-deficient thymocytes. Total thymocytes were either unstimulated or stimulated with
plate-bound anti-CD3 and soluble anti-CD28 for 3 days for CFSE-labeling experiment, or for 18 hr followed by 6 hr of incubation with brefeldin A
for IL-2 production assay. Top, histograms show the CFSE-fluorescent intensity of unstimulated thymocytes (shadow), CD4+ (solid line), or CD8+
(dashed line) after stimulation with anti-CD3 and anti-CD28. Bottom, dot plots show intracellular staining of IL-2 in gated CD4+, CD8+, and DP
thymocytes. For DP cells, only CD8 staining is shown in the y axis.Most TCR-Proximal Signaling Pathways Were Not
Spontaneously Activated in Cbl Double-Deficient
Thymocytes
Development of Cbl2/2, Cblb2/2 CD4+ and CD8+ T cells
in the absence of the MHC suggests that the Cbl double
deficiency results in spontaneous activation of the CD4+
and CD8+ lineage-development program. To assess this
possibility, we examined various TCR-proximal signal-
ing pathways in Cbl2/2, Cblb2/2 DP thymocytes in the
presence or absence of anti-CD3 stimulation. To elimi-
nate background signaling elicited by intrathymic stimuli
in vivo, we cultured thymocytes at 37C for 10–12 hr
in vitro before biochemical analysis. This treatmenthas been shown to eliminate the basal TCR signaling
activated by the MHC molecules that are expressed on
thymic accessory cells (Nakayama et al., 1991). In the
absence of anti-CD3 stimulation, we could not find sub-
stantial amounts of spontaneous tyrosine phosphoryla-
tion of the total cellular proteins or individual signaling
components such as LAT, Zap70, Vav, PLCg-1, and
Erk1 and 2 (Figures 4A and 4B), suggesting that the
TCR-proximal signaling events examined above are
not spontaneously activated in Cbl2/2, Cblb2/2 thymo-
cytes in the absence of TCR stimulation. After anti-
CD3 stimulation, the magnitude of tyrosine phosphory-
lation of total cellular proteins was not measurably
Immunity
576Figure 4. Intracellular Signaling of Cbl2/2, Cblb2/2 and Wild-Type Thymocytes
(A and B) FACS-purified DP thymocytes or total thymocytes were stimulated with anti-CD3, anti-CD3 + anti-CD4, or anti-CD3 + anti-CD8 for
2 min. Shown are tyrosine phosphorylation of total cellular proteins (A) or individual signaling proteins (B). Erk1 and 2 activities were determined
with an antibody against the active forms of Erk1 and 2.
(C) TCR-induced Ca2+ mobilization. Shown are the histograms of Ca2+ mobilization in wild-type (dashed line) and Cbl2/2, Cblb2/2 (solid line) DP
thymocytes. CD4+CD8+ thymocytes are gated and displayed as a ratio of fluo 4 versus fura-red intensity. Arrows indicate the time points when
anti-CD33-biotin and straptavidin (SAV) were added.enhanced, and in some cases, for example p90 and p36-
p38, was even weakened inCbl2/2, Cblb2/2 thymocytes
as compared to that in wild-type cells (Figures 4A and
4B). The strong phosphorylated 120 kDa protein band
in wild-type cells, which was absent in Cbl2/2, Cblb2/2
cells, might represent tyrosine phosphorylated c-Cbl,
as indicated by the fact that preclearing of c-Cbl from
the lysates via anti-c-Cbl depleted this band
(Figure S3). Tyrosine phosphorylation of CD3z chain
and Zap70 was augmented. However, tyrosine phos-
phorylation of p36-p38 (possibly LAT) and PLCg-1 was
markedly reduced in Cbl2/2, Cblb2/2 thymocytes, sug-
gesting that the enhanced CD3z chain and Zap70 sig-
nals could not be efficiently transduced to downstream
targets in the absence of c-Cbl and Cbl-b. Consistent
with the weaker tyrosine phosphorylation of PLCg-1,
TCR-induced Ca2+ mobilization was also attenuated in
Cbl2/2, Cblb2/2 DP thymocytes (Figure 4C). These re-
sults collectively indicate that the TCR-proximal signal-
ing pathways studied above are neither spontaneously
activated nor generally hyperactive in Cbl2/2, Cblb2/2
thymocytes.
Constitutive Hyperactivation of NF-kB in Cbl2/2,
Cblb2/2 Thymocytes
Our finding that in Cbl2/2, Cblb2/2 thymocytes most
TCR-proximal signaling pathways are not spontane-
ously activated suggests that the Cbl double deficiency
might affect the TCR-distal signaling cascade. Since
development of CD4+ and CD8+ T cells is controlled
by a series of transcription factors, we next examined
the activities of several transcription factors that are
known to be essential for CD4+- and CD8+-lineage
development.
NF-kB is a transcription factor that can be activated
by the TCR (Kane et al., 2002). Enforced activation of
NF-kB may substitute pre-TCR and TCR signals to sup-
port the development and survival of DP and CD4+ and
CD8+ thymocytes (Voll et al., 2000). We found that, incontrast to wild-type thymocytes in which NF-kB bind-
ing activity was moderately enhanced only after TCR
stimulation, Cbl2/2, Cblb2/2 thymocytes exhibited a
markedly higher level of NF-kB binding activities even
in the absence of TCR stimulation (Figure 5). The consti-
tutive activation appeared to be selective for NF-kB
because the activity of AP-1, another transcription fac-
tor whose activation depends on TCR-induced MAP
kinases, was not spontaneously active in Cbl2/2,
Cblb2/2 cells (Figure 5). Based on these results, we con-
clude that the signaling cascade upstream of the NF-kB
pathway is constitutively active in Cbl2/2, Cblb2/2 thy-
mocytes. Since NF-kB activation may substitute TCR
signaling in promoting T cell development (Voll et al.,
Figure 5. Constitutive Activation of NF-kB in Cbl2/2, Cblb2/2 Thy-
mocytes
DP thymocytes were purified by FACS sorting. The purified cells
were either left unstimulated or stimulated with plate-bound anti-
CD3, anti-CD3 + anti-CD28, or PMA and Ionomycin. NF-kB and
AP-1 activities were determined by EMSA with oligonucleotides of
NF-kB and AP-1 binding sites as probes, respectively. Oct 1 binding
activities were used as protein quantity controls.
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Signaling in Cbl2/2, Cblb2/2 DP Thymocytes
(A) Shown are histograms of pTa expression
on DN, DP, CD4+, and CD8+ thymocytes
from wild-type (top) and Cbl2/2, Cblb2/2
mice (bottom). Shadow, thymocyte subsets
stained with isotype-matched control anti-
body. Solid line, thymocytes stained with
anti-pTa.
(B) Lck (Y394) phosphorylation and tyrosine
phosphorylation of CD3z chain. Left, tyrosine
phosphorylation of Lck (Y394) in total thymo-
cytes either with or without anti-CD3 + anti-
CD4 stimulation (top left) or in purified DP thy-
mocytes without stimulation (bottom left).
Phosphorylation of Lck (Y394) was deter-
mined with an anti-Lck (Y394). Right, tyrosine
phosphorylation of CD3z chain in total thy-
mocytes either with or without anti-CD3 +
anti-CD4 stimulation (top right) or in purified
DP thymocytes without stimulation (bottom
right). In the latter, the amounts of Zap70
were used as protein loading controls.2000), our data also suggest that the constitutive activa-
tion of NF-kB is one of the reasons contributing to the
loss of MHC-dependent T cell development in the mu-
tant mice.
Impaired Pre-TCR Downmodulation and Constitutive
Pre-TCR Signaling in Cbl2/2, Cblb2/2 DP
Thymocytes
It is generally believed that the TCR and the pre-TCR
deliver signals through the same CD3 complexes; how-
ever, unlike the TCR, the pre-TCR is constitutively active
even in the absence of MHC engagement (Panigada
et al., 2002; Yamasaki et al., 2006). Cbl proteins may
attenuate TCR signaling through promotion of TCR
downmodulation, so we speculated that the spontane-
ous activation of the CD4+ and CD8+ T cell development
programs in Cbl2/2, Cblb2/2 thymocytes might be trig-
gered by enhanced pre-TCR signaling, resulting from
impaired pre-TCR downmodulation. We found that in-
deed pre-TCR expression was much higher on Cbl2/2,
Cblb2/2 DN and DP thymocytes than on wild-type con-
trols; however, the expression of pre-TCR was only min-
imally increased on the mutant CD4+ thymocytes but not
detectable on the mutant CD8+ thymocytes nor on the
peripheral CD4+ and CD8+ T cells (Figure 6A and data
not shown). To determine whether pre-TCR signaling
is constitutively enhanced in Cbl2/2, Cblb2/2DP thymo-
cytes, we examined pre-TCR downstream signaling
including Lck activation and tyrosine phosphorylation
of CD3z chain in Cbl2/2, Cblb2/2 DP thymocytes. We
found that even in the absence of TCR stimulation, the
mutant total thymocytes as well as purified DP T cells
possessed significantly higher levels of Lck (Y394) phos-
phorylation, which represents the active form of Lck,
and of tyrosine phosphorylated CD3z chain (p21) than
did the wild-type controls (Figure 6B). These data indi-
cate that pre-TCR signaling is indeed enhanced inCbl2/2, Cblb2/2 DP thymocytes and support our hy-
pothesis that the enhanced pre-TCR signaling is at least
one of the reasons responsible for constitutive NF-kB
activation and MHC-independent development of
CD4+ and CD8+ T cells.
Discussion
MHC-dependent recognition is established during T cell
development in thymus in which only those T cells ex-
pressing a TCR that recognizes either MHC-I or MHC-
II are permitted to develop further into CD4+ or CD8+ T
cells (Fink and Bevan, 1978; Fowlkes and Pardoll,
1989; von Boehmer, 1988). Our study reveals that Cbl
proteins play a critical role in T cell development at mul-
tiple stages, particularly in controlling the program re-
sponsible for MHC-dependent CD4+ and CD8+ T cell
genesis. In the absence of c-Cbl and Cbl-b, both
CD4+- and CD8+-lineage T cells are efficiently generated
in thymi even in the absence of MHC-I and II, indicating
that Cbl proteins function as a barrier to prevent ‘‘unau-
thorized’’ (MHC-independent) CD4+ and CD8+ T cell de-
velopment under physiological conditions. Interestingly,
Cbl2/2, Cblb2/2 CD4+ and CD8+ T cells generated in
Cbl-MHC quadruple-deficient mice do not accumulate
in the peripheral lymphoid organs. Since the survival of
peripheral T cells depends on TCR-MHC interaction (Kir-
berg et al., 1997; Takeda et al., 1996; Tanchot et al.,
1997; Viret et al., 1999; Witherden et al., 2000), our obser-
vation may suggest that the survival signals in Cbl2/2,
Cblb2/2CD4+ and CD8+ T cells are not constitutively ac-
tive. Alternatively, it is possible that Cbl2/2, Cblb2/2
CD4+ and CD8+ T cells cannot exit the thymus in the ab-
sence of the MHC. It has been shown that thymocyte
egress from thymi depends on sphingosine-1 phos-
phate (S1P) signaling that is upregulated in newly gener-
ated mature thymocytes (Matloubian et al., 2004). In this
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siveness to S1P is diminished in Cbl-MHC quadruple-
deficient CD4+ and CD8+ thymocytes.
The multiple effects on thymocyte development by
the Cbl double deficiency may involve different mecha-
nisms. Cbl2/2, Cblb2/2 thymi contain a significantly low
number of thymocytes as compared to that in wild-type
mice. This defect is not likely a result of reduced DN cell
proliferation, but rather can be attributed to the en-
hanced thymic negative selection, resulting in depletion
of DP thymocytes that usually are positively selected
and develop into CD4+ or CD8+ thymocytes in wild-
type mice. As for the altered ratio of CD4+ and CD8+ lin-
eages and MHC-independent development of CD4+ and
CD8+ T cells in the mutant mice, we propose that the Cbl
double deficiency regulates these development pro-
grams through a different mechanism. It is generally be-
lieved that the development program for the CD4+ and
CD8+ lineages is controlled by TCR signals that may in-
fluence CD4+ and CD8+ lineage choice through different
strength and duration (Germain, 2002). Our finding that
Cbl2/2, Cblb2/2 CD4+ and CD8+ T cells may develop in
the absence of the MHC thus suggests that TCR signal-
ing is constitutively active in Cbl2/2, Cblb2/2 thymo-
cytes. Although our experiments show that the majority
of TCR-proximal signaling pathways are not spontane-
ously activated in Cbl2/2, Cblb2/2 thymocytes, we in-
deed find that NF-kB but not AP-1 transcription factors
are constitutively hyperactive in the mutant cells even
in the absence of TCR stimulation. NF-kB controls cell
development, death, and survival (Ghosh and Karin,
2002). Under physiological conditions, however, consti-
tutive NF-kB activity is restricted to DN3 and DN4 popu-
lations and is likely to be induced by pre-TCR signaling
(Aifantis et al., 2001; Voll et al., 2000). It has been
reported that enforced expression in thymocytes of a
‘‘superinhibitor’’ of NF-kB, which inhibits endogenous
NF-kB activation by 3- to 4-fold, suppresses DN4 thy-
mocyte development. In contrast, expression of a con-
stitutively active form of IkB kinase b in Rag22/2 thymo-
cytes, which results in a 2- to 3-fold increase in NF-kB
activity, promotes Rag22/2 thymocyte differentiation
into DP T cells (Voll et al., 2000). Interestingly, in thymi
of the IkB kinase b transgenic mice, a small number of
Rag22/2 CD4+ and CD8+ thymocytes emerge and there
are more CD8+ T cells than CD4+ cells, thus suggesting
that the hyperactivation of NF-kB alone may be suffi-
cient to substitute TCR signaling, leading to a biased ra-
tio and MHC-independent development of CD4+ and
CD8+ cells (Voll et al., 2000). Finally, it should be men-
tioned that in addition to the TCR, development of
CD4+- and CD8+-lineage T cells is also regulated by
Notch. At the present time, we cannot exclude the pos-
sibility that Notch signaling is altered in Cbl2/2, Cblb2/2
thymocytes. Notch 1 has been shown to be ubiquiti-
nated by c-Cbl in myoblasts in an overexpression exper-
iment (Jehn et al., 2002). Therefore, it will be interesting
to examine whether Notch ubiquitination and expres-
sion is affected in thymocytes in the absence of Cbl
proteins.
How can c-Cbl and Cbl-b selectively regulate NF-kB
but not AP-1 activation in developing thymocytes? At
present, it is not well understood how TCR signaling ac-
tivates NF-kB in thymocytes. Because Cbl proteinsfunction as E3 ubiquitin ligases, they may control
NF-kB activation by selectively promoting ubiquitination
and degradation of signaling components that act be-
tween the TCR and NF-kB, but not AP-1. Bcl-10,
Carma-1, PKCq, and MALT-1 are candidate compo-
nents that meet this criterion (Li and Verma, 2002; Ru-
land et al., 2001; Thome and Tschopp, 2003; Wang
et al., 2004). Therefore, it is worthwhile to examine
whether ubiquitination and degradation of these pro-
teins are altered inCbl2/2, Cblb2/2 thymocytes. Alterna-
tively, we favor an idea that constitutive NF-kB acti-
vation in Cbl2/2, Cblb2/2 thymocytes results from
impaired pre-TCR downmodulation and degradation,
since the pre-TCR signals constitutively through the
CD3 complex in the absence of ligand stimulation (Aifan-
tis et al., 2001). It has been shown that pre-TCR down-
modulation and degradation depend on c-Cbl (Panigada
et al., 2002). We found that pre-TCR expression was
markedly upregulated on Cbl2/2, Cblb2/2 DN and DP
thymocytes that correlated with constitutive Lck activa-
tion and CD3z chain phosphorylation in the mutant DP
cells (Figure S5), thus indicating that the pre-TCR signal-
ing is enhanced in these cells. However, since pre-TCR
signaling activates multiple TCR signaling pathways in
addition to NF-kB, other mechanisms must be involved
in order to explain how the Cbl double deficiency selec-
tively affects activation of NF-kB, but not that of AP-1.
One possible explanation is that the Cbl double defi-
ciency might also elicit other signaling pathways that se-
lectively suppress pre-TCR-induced branch signaling
leading to AP-1, but not NF-kB activation. One candi-
date molecule along this line is CD148, a transmembrane
phosphatase that may selectively dephosphorylate LAT
and PLC-g in Jurkat T cells (Baker et al., 2001). This
possibility is supported by our preliminary data showing
that CD148 is markedly upregulated on Cbl2/2, Cblb2/2
DP thymocytes (Figure S4). Additionally, it is also con-
sistent with our observation that despite an enhanced
tyrosine phopshorylation of CD3z chain, tyrosine phos-
phorylation of PLC-g and p36-38 (possibly LAT) appears
to be attenuated in Cbl2/2, Cblb2/2 thymocytes. Taken
together, current data from our laboratory and others
are consistent with our hypothesis that Cbl proteins
switch MHC-independent pre-TCR signaling to MHC-
dependent TCR signaling in DP thymocytes, and failure
to do so may result in constitutive activation of pre-TCR
signaling pathways, such as NF-kB, consequently pro-
moting T cell differentiation into CD4+ and CD8+ T cells
in the absence of the MHC. Further genetic studies,
with mice in which pre-TCR signaling is either attenu-
ated or ablated in DP T cells, may help to determine
whether the impaired pre-TCR downmodulation is the
sole contributor to constitutive NF-kB activation and
whether this is sufficient to drive the MHC-independent
development of CD4+ and CD8+ T cells.
Stimulation through the TCR activates a series of co-
ordinated intracellular signaling events that control the
CD4+ and CD8+ lineage-development program. How-
ever, it is worthwhile to notice that these individual sig-
naling events can also be activated by receptors other
than the TCR (Dikic and Blaukat, 1999; Ghosh and Karin,
2002; Jorissen et al., 2003; Sanchez-Martin et al., 2004;
Zell et al., 1999). In particular, the pre-TCR, which also
signals through the CD3 complex, activates a signaling
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et al., 2001). In this regard, it is conceivable that activa-
tion of these signals by receptors other than the TCR in
the thymic environment may generate basal level signal-
ing in the TCR signaling cascade and that loss of control
over these ‘‘tonic’’ signals may result in accumulation of
the transcription activities required for T cell develop-
ment. Thus, by eradicating this ‘‘tonic’’ signaling, Cbl
proteins may enforce use of the TCR to activate the
CD4+ and CD8+ T cell development program under
physiological conditions, thus establishing an MHC-
dependent mechanism for T cell development and
differentiation.
One may envisage that loss of MHC dependence dur-
ing T cell development might lead to the generation of T
cells that recognize antigens outside of the context of
MHC presentation. These cells may exist only in small
numbers and may receive stimulation from native auto-
antigens in the periphery. The survival and activation of
these cells would be dangerous for animals because
they could potentially cause autoimmune diseases. In
this regard, Cbl2/2, Cblb2/2 mice indeed developed se-
vere systemic autoimmune vasculitis (Naramura et al.,
2002). Given thatCbl2/2, Cblb2/2mice exhibit enhanced
thymic negative seletion, which should eliminate autor-
eactive cells more efficiently, it will be of great interest
to determine whether the development of the autoim-
mune disease involves non-MHC-restricted autoreac-
tive T cells. Finally, our preliminary data suggest that
Cbl2/2, Cblb2/2 T cells are resistant to TGF-b suppres-
sion (data not shown). It is feasible that Cbl2/2,
Cblb2/2 T cells may escape negative regulation of
TGF-b secreted by regulatory T cells. In conclusion,
our data demonstrate that Cbl proteins play multiple
functions in T cell development, function, and autoim-
munity. Further dissection of signaling controlled by
Cbl proteins may be useful for immunomodulation.
Experimental Procedures
Mice
Generation of c-Cbl floxed (Cblf/f) and Cblb2/2 mice has been de-
scribed previously (Chiang et al., 2000; Naramura et al., 2002). The
Lck-cre transgenic (Tg) mice were kindly provided by J. Takeda (Ta-
kahama et al., 1998). To generate Cbl2/2, Cblb2/2 mice (Cbl2/2,
Cblb2/2), we crossed Cblf/f mice to Lck-cre Tg mice and then
crossed their offspring with Cblb2/2 mice to obtain Cblf/f, Cblb2/2,
Lck-cre Tg mice. The genotypes of these mice were determined
by Southern blot hybridization according to a previous protocol
(Naramura et al., 2002). Cbl-MHC quadruple-deficient mice were
obtained by crossing Cbl2/2, Cblb2/2 mice to MHC-I and II double-
deficient mice (B2m2/2, Abb2/2). C57BL/6 Rag22/2, MHC-I-
deficient (B2m2/2), and MHC-I and II double-deficient mice were
from Taconic (Germantown, NY). These mice were kept in specific
pathogen-free facilities at the NIH and Columbia University. Animal
experiments were approved by the Institutional Animal Care and
Use Committees of the National Institute of Allergy and Infectious
Diseases, NIH, and Columbia University.
Flow Cytometric Analysis
To study thymocyte cellularities, we collected total thymocytes from
wild-type and mutant mice and prepared them as single-cell sus-
pensions. For fluorescent staining, we stained 1 3 106 cells in PBS
buffer containing 0.5% BSA and 0.05% azide with fluorescent-
coupled antibodies on ice for 30 min. After staining, we washed cells
twice with PBS buffer and analyzed the staining profiles on a FACS
LSR II (BD Biosciences, San Diego, CA). To examine the develop-
ment of the CD4+ and CD8+ lineage T cells, we stained total thymo-cytes with different fluorescent-coupled CD4, CD8, TCRb, and HSA
antibodies. To examine the development of DN thymocytes, we
stained total (CD32 CD42 CD82 B2202 TCRgd2 NK1.12 Gr-12
Mac-12) thymocytes with CD44, CD25, and CD117/c-Kit antibodies.
The subpopulations of DN1-4 thymocytes were defined as DN cells
that express CD117+ CD44+CD252, CD117+ CD44+CD25+, CD1172
CD442CD25+, and CD1172 CD442CD252 markers, respectively
(Godfrey et al., 1993). Antibodies used are the following: anti-CD4
(RM4-5), anti-CD8a (53-6.7), anti-B220 (RA3-6B2), anti-Mac-1 (M1/
70), anti-Gr-1 (RB6-8c5), anti-NK1.1 (PK136), anti-TCRb (H57-597),
anti-TCRgd (GL3), anti-CD44 (1M7), anti-CD117 (2B8), anti-CD25
(7D4), anti-HSA (M1/69), and anti-pTa (Pharmingen, San Diego,
CA). The data were analyzed with FlowJo software (Tree Star, Inc.,
Ashland, OR).
Cell Transfer and Bone Marrow Chimera Studies
We excluded the possible influence of inflammation on the develop-
ment of Cbl2/2, Cblb2/2 thymocytes in mixed stem-cell bone mar-
row chimeras. To generate these chimeras, we intraperitoneally
injected wild-type (H-2Kb/b) and Cbl2/2, Cblb2/2 (H-2Kd/b) mice (4–
5 weeks old) with 5 mg of 5-fluorouracil (5-FU) to deplete the actively
dividing BM cells. Five days later, BM cells were recovered from the
mice, mixed in a 1:1 ratio (13 106 from each donor), and then trans-
ferred into lethally irradiated (900 Rads) Rag22/2 recipient (H-2Kb/b)
mice by i.v. injection. One month later, thymocytes were recovered
from these BM chimeras and subjected to flow cytometric analysis.
Cbl2/2, Cblb2/2 thymocytes developed in the recipient mice were
distinguished from wild-type cells by flow cytometry with antibody
against H-2Kd (34-2-12, Pharmingen). To examine the dependence
of T cell development on MHC-I alone or on both MHC-I and II, we
generated BM chimeras with 50-FU-treated Cbl2/2, Cblb2/2 and
Cbl-b2/2 mice as the donors and lethally irradiated MHC-I-deficient
(B2m2/2) or MHC-I and II double-deficient (B2m2/2, Abb2/2) mice as
the recipients. One month later, we analyzed the development of
CD4+ and CD8+ lineage cells on a FACS LSR II after staining the cells
with anti-Ly9.1 (30C7, Pharmingen), anti-CD4, and anti-CD8. Donor
cells were Ly9.1+ so they could be distinguished from the recipient
cells (Ly9.12) based on Ly9.1 expression.
Biochemical Studies
We used total thymocytes or purified DP thymocytes for biochemi-
cal analyses. DP thymocytes were purified by FACS sorting. Activa-
tion of individual signaling events in thymocytes induced by the TCR
was examined according to previously published protocols (Nara-
mura et al., 1998). In brief, to determine tyrosine phosphorylation
of total cellular proteins, we stained 13 107 total or purified DP thy-
mocytes with biotinylated anti-CD33 (145-2C11) (5 mg/ml) alone or
together with biotinylated anti-CD4 or CD8 (each 5 mg/ml) followed
by straptavidin (10 mg/ml) at 37C for 2 min. Cells were then lysed
in RIPA buffer supplemented with proteinase and phosphatase in-
hibitors. Tyrosine phosphorylation of total proteins or activation of
Erk1/2 in the lysates was determined by immunoblot with antibodies
against phosphotyrosine (4G10, Upstate Biotech, Charlottesville,
VA) or the anti-active forms of Erk1 and 2 (E10, New England Biolabs,
Beverly, MA). To determine the tyrosine phosphorylation of Zap70,
Vav, CD3z chain, and PLCg-1, we immunoprecipitated the corre-
sponding proteins from the cell lysates and examined the levels of
tyrosine phosphorylation of these proteins by western blot hybrid-
ization with 4G10 antibody. The antibodies used for immunoprecip-
itation were: anti-Zap70 (sc 574 AC), anti-Vav (H-21), anti-CD3z
(C-20), and anti-PLCg-1 (sc-426) (Santa Cruz Biotechnologies, Inc,
Santa Cruz, CA). To determine Ca2+ mobilization, total thymocytes
were loaded with Fluo-4 and Fura-red (Molecular Probes, Eugene,
OR), surface stained with anti-CD4 and anti-CD8, and then stimu-
lated with biotinylated anti-CD33 (1 mg/ml) and straptavidin (5 mg/
ml). Ca2+ influx were determined by flow cytometry according to
a previously published protocol (Naramura et al., 2002). To
determine the amount of Lck (Y394) phosphorylation, membrane
was directly hybridized with rabbit anti-phosphorylated Lck (Y394)
antibody (a gift from Andrey Shaw).
Thymocyte Proliferation and IL-2 Production Assay
To measure thymocyte proliferation, CFSE-labeled total thymocytes
(105 cells/well) were stimulated in 96-well plate with plate-bound
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the stimulation, cells were stained with anti-CD4 and anti-CD8
and then analyzed on an LSR II. For IL-2 production assay, cells
were stimulated with plate-bound anti-CD3 (5 mg/ml) and soluble
anti-CD28 (5 mg/ml) for 18 hr followed by incubation with 10 mg/ml
Brefeldin A for 6 hr. After stimulation, cells were surface stained
with anti-CD4 and anti-CD8, permeabilized, and intracellularly
stained with anti-IL-2 before being subjected to FACS analysis.
Electrophoresis Mobility Gel Shift Assay
We stimulated DP thymocytes with plate-bound anti-CD33 (5 mg/ml)
alone or together with soluble anti-CD28 (5 mg/ml) or PMA (10 ng/
ml) + Ionomycin (10 ng/ml) for 8–10 hr at 37C. For unstimulated
cells, we cultured DP thymocytes in the normal medium in the ab-
sence of stimuli antibodies. Nuclear extracts were prepared and
EMSAs conducted according to a previous protocol (Sun et al.,
2000). To assess the binding activities of the corresponding nuclear
factors, we used the following oligonucleotides: NF-kB: 50-ACCAA
GAGGGATTTCACCTAAATC-30; AP-1: 50-CGCTTGATGACTCAGCC
GGAA-30.
Supplemental Data
Five Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/4/571/DC1/.
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